Purpose: To evaluate the results of the porous polyethylene (Medpor) orbital implantation technique combined with the use of a primary patch graft of acellular dermis.
Methods: The study design was a retrospective, non-comparative single surgeon case series of 27 patients. The Medpor orbital implant was placed with a primary anterior sub-Tenon's acellular dermis patch after evisceration (23/27), enucleation (2/27) or implant exchange/secondary implant procedure (2/27) over a period of 3 years. Risk factors for dehiscence/complications were defined as trauma, infection, inflammation, previous ocular surgery, radiotherapy, secondary orbital implantation, and removal of extruding implants. The primary outcome measure was the development of implant exposure. Other complications were also recorded, including postoperative conjunctival wound dehiscence.
Results: Twenty-five patients (93%) had more than 2 risk factors. Mean follow-up time was 22 months (median 24 months, range 4-34 months). Three (11%) patients needed further intervention, which included pyogenic granuloma excision (1) and fornix formation (1). Conjunctival wound dehiscence followed by implant exposure occurred in 1 of 27 eyes (3.7%). The cosmetic appearance was satisfactory in 26/27 patients.
Conclusions: Our results with primary acellular dermis grafts when coupled with Medpor orbital implantation are encouraging.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/01676830601168900 | DOI Listing |
Am J Transl Res
November 2024
Department of Ophthalmology, Bethune International Peace Hospital Shijiazhuang 050082, Hebei, China.
Int J Ophthalmol
October 2024
National Metal and Materials Technology Center (MTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.
Aim: To compare the exposure rate, infection rate, percentage of enhancement, and success rate between Medpor and the three-dimensional printed polyethylene (3DP-PE) orbital implant in a preliminary report.
Methods: This prospective, randomized, equivalence, controlled trial was conducted at two institutes. The equivalent margin was ±10%.
Arch Craniofac Surg
October 2024
Department of Plastic Reconstructive Surgery, Chosun University College of Medicine, Gwangju, Korea.
Eplasty
May 2024
Department of Otolaryngology, University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee.
J Craniofac Surg
May 2024
The Second Department of Craniomaxillofacial Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!